Significant independent risk factors for infections were a higher Charlson Comorbidity Index, IgG deficiency, and 3rd + line treatment, as well as therapy with BTK inhibitors or chemotherapy in CLL. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.